Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
Authors
Courtney P. Olwagen (ORCID: https://orcid.org/0009-0007-3674-8415)
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
Courtney P. Olwagen, Amit J Nana, Alane Izu, Anthonet Koen et al.
Journal
Expert Review of Vaccines
Topics
Pneumonia and Respiratory Infections
article
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
Courtney P. Olwagen, Amit J Nana, Alane Izu, Anthonet Koen, Lisa Jose, Shabir Ahmed Madhi, Eleonora A.M.L. Mutsaerts, Clare Cutland
article en
Abstract
No abstract available for this paper.
Publication Tag
Expert Review of VaccinesVol. 24(1)
Institutions
South African Medical Research Council (ZA), University of the Witwatersrand (ZA), Emma Kinderziekenhuis (NL), Amsterdam University Medical Centers (NL), National Research Foundation (ZA), University of Amsterdam (NL)
Funders
Bill and Melinda Gates Foundation, Medical Research Council